Discover Ascendis Pharma's innovative patent for hydrogel prodrug compositions u...
A combo trial will continue as planned in addition to the biotech’s cutaneous T ...
Discover the groundbreaking patent by Chinook Therapeutics for improving kidney ...
The FDA has approved Duvyzat for Duchenne muscular dystrophy patients aged six y...
Lisata Therapeutics announced a rare pediatric drug designation for LSTA1, which...
Download our free, comprehensive list of the leading companies within the pharma...
Download our free list of leading pharmaceutical consulting companies and traini...
Bionomics plans to meet with the FDA following positive topline data from the Ph...
Capstan Therapeutics has secured $175m Series B financing to advance its lead in...
Panellists discuss opportunities and challenges in cell and gene therapies at th...
Biotech executives discuss why developing gene therapies for central nervous sys...
Merck KGaA has announced an investment of over €300m ($326.1m) to establish a ne...
Lilly says that the FDA wants to look closer at efficacy implications of the Pha...
Different therapeutic approaches against antibiotic-resistant bacteria were high...
Nouscom is part of a cancer vaccine landscape that has recently jump-started fol...
The Phase III KEYLYNK-006 study evaluating a Keytruda/Lynparza combination treat...